Zobrazeno 1 - 10
of 18
pro vyhledávání: '"T. L. Galankin"'
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 26, Iss 3, Pp 78-85 (2020)
Introduction. Nowadays, lipid-lowering therapy is considered an essential strategy for primary and secondary prevention of cardiovascular outcomes, which is confirmed by numerous studies. Nevertheless, researches are often guided by analysis of surro
Externí odkaz:
https://doaj.org/article/e1dc1f1187604cadbaf5e16f518a5dd7
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 41-52 (2018)
A health economic study was conducted under the Russian economic conditions to evaluate the feasibility of the use of dexamethasone 0.7 mg as a sustained release intravitreal implant (hereinafter, DEX implant) in the treatment of diabetic macular ede
Externí odkaz:
https://doaj.org/article/68cf81d9d5804d588fefc8af4ebd955a
Autor:
Sean D. Sullivan, Josephine A. Mauskopf, Federico Augustovski, J. Jaime Caro, Karen M. Lee, Mark Minchin, Ewa Orlewska, Pete Penna, Jose-Manuel Rodriguez Barrios, Wen-Yi Shau, T. L. Galankin, A. A. Mosikyan, A. S. Kolbin
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 104-118 (2018)
Background. Budget impact analyses (BIAs) are an essential part of a comprehensive economic assessment of a health care intervention and are increasingly required by reimbursement authorities as part of a listing or reimbursement submission. Objectiv
Externí odkaz:
https://doaj.org/article/4dd2601a855f4d5495eb7529ce2631e0
Publikováno v:
Журнал инфектологии, Vol 10, Iss 1, Pp 96-102 (2018)
The purpose of the study. To evaluate immunogenicity of influenza vaccination in HIV-infected adults initially seronegative to influenza virus.Materials and methods. There were 175 HIV-infected persons and 50 healthy volunteers vaccinated against inf
Externí odkaz:
https://doaj.org/article/a4dd07182e304cd182f7ee86e16e2189
Autor:
I. S. Moiseev, T. L. Galankin, A. A. Dotsenko, E. A. Burmina, Y. G. Fedukova, E. I. Darskaya, A. V. Kozlov, T. A. Bikova, L. S. Zubarovskaya, B. V. Afanasyev
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 25, Iss 1, Pp 35-44 (2018)
Introduction. Steroid-refractory graft-versus-host disease (srGVHD) is one of the most severe and life-threatening complications of allogeneic hematopoietic stem cell transplantation. Currently, there is no standard treatment for this complication. I
Externí odkaz:
https://doaj.org/article/dc5f22674c1747699865975c4f5b183e
Publikováno v:
Фармакоэкономика, Vol 10, Iss 3, Pp 47-58 (2017)
The process of decision modelling in diabetes mellitus (DM) is often complicated by comorbidity among diabetic patients, complexity of endpoint selection, and unclear time horizons. Aim. To review the available recommendations, relevant methods and m
Externí odkaz:
https://doaj.org/article/d66fb85716284a7fa28ef2cd68b75d9d
Autor:
A. S. Kolbin, L. S. Namazova-Baranova, E. A. Vishneva, M. Y. Frolov, T. L. Galankin, A. A. Alekseeva, E. A. Dobrynina
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 4, Pp 345-353 (2016)
Background: Omalizumab is the first and yet the only biopreparation for asthma which combines high efficiency and high cost. The clinical-economic expediency of using omalizumab in asthmatic children has not been previously studied in Russia.Objectiv
Externí odkaz:
https://doaj.org/article/0e252e0ddb904b8fb3d434922a59527c
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 3, Pp 232-238 (2016)
The predictability of results of pediatric clinical trials is often limited for a number of reasons. Among the main ones is the imperfect functioning of organ due to immature ontogeny of enzyme and organ systems in children, and the presence of speci
Externí odkaz:
https://doaj.org/article/d79ada3432864fd58993cb6bce0018b4
Autor:
T. L. Galankin, A. S. Kolbin
Publikováno v:
Фармакоэкономика, Vol 7, Iss 1, Pp 4-8 (2015)
Abstract: pharmacoepidemiology has recently evolved into a self-dependent post-marketing disciplinefrom clinical pharmacology, borrowing its methodology and analyticaltools from epidemiology. The article describes the goals of pharmacoepidemiology an
Externí odkaz:
https://doaj.org/article/2ffe25d0640e435a9c5771d8847c023a
Publikováno v:
Učenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova, Vol 26, Iss 3, Pp 78-85 (2020)
Introduction.Nowadays, lipid-lowering therapy is considered an essential strategy for primary and secondary prevention of cardiovascular outcomes, which is confirmed by numerous studies. Nevertheless, researches are often guided by analysis of surrog